Zoilo Núñez Gil¹ and Otto Alemán Miranda²

¹Professor of Anatomy and Maxillofacial Surgical Pathology. Head of the Maxillofacial Surgery Service of the Regional Hospital Saint Vincent de Paul University. Head of the Maxillofacial Surgery Service of the National Institute of Cancer. (INCART) Santo Domingo. Dominican Republic
²General Clinical and Surgical Hospital Orlando Pantoja Tamayo, Cuba

*Corresponding Author: Otto Alemán Miranda, General Clinical and Surgical Hospital Orlando Pantoja Tamayo, Cuba.

Received: August 21, 2023; Published: September 23, 2023

Abstract

Treatment of patients with coexisting cardiovascular disease (heart problems) often raises concerns about possible problems during dental treatment. The incidence of Cardiovascular Diseases (CVD) increased from the beginning of the century to the point where it became the leading cause of death in industrialized countries as each country changed its traditional lifestyles. Therefore, an exhaustive bibliographical review was carried out to argue the main risk factors that occur in patients with heart disease in relation to dentistry.

Keywords: Orofacial Manifestations; Risks; Heart Disease; Bleeding; Haemorrhage; Thrombi

References

1. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by region, 2000-2016. Geneva, World Health Organization (2018).
2. Aghaloo T. “Dental management of patients with coronary artery disease”. Journal of the California Dental Association 23 (1995): 41-46.
3. G Mancia., et al. “ESH/ESC guidelines for the management of arterial hypertension: the task forcé for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)”. Journal of Hypertension9 (2007): 1751-1762.
4. V Chobanian., et al. “The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report”. Journal of the American Medical Association19 (2004): 2560-2572.
5. RS Vasan., et al. “Impact of highnormal blood pressure on the risk of cardiovascular disease”. The New England Journal of Medicine18 (2001): 1291-1297.
6. V Chobanian., et al. “The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report”. Journal of the American Medical Association19 (2003): 2560-2572.
7. J Hogan and J Radhakrishnan. “The assessment and importance of hypertension in the dental setting”. Dental Clinics of North America 56 (2012): 731-745.
8. M Dorobantu., et al. “Prevalence, awareness, treatment, and control of hypertension in Romania: results of the SEPHAR study”. International Journal of Hypertension 970694 (2010): 6.
9. NM Kaplan. “Primary hypertension. from pathophysiology to prevention”. Archives of Internal Medicine17 (1996): 1919-1920.
10. H Snieder., et al. “Heritability of blood pressure and hemodynamics in African- and EuropeanAmerican youth”. Hypertension6 (2003): 1196-1201.
11. MS Kaplan and A Nunes. “The psychosocial determinants of hypertension”. Nutrition, Metabolism and Cardiovascular Diseases 1 (2003): 52-59.
12. NM Kaplan. “Management of hypertensive patients with multiple cardiovascular risk factors”. American Journal of Hypertension6 (2001): 221S-224S.
13. Muntner P., et al. “Measurement of blood pressure in humans: A scientific statement from the American Heart Association”. Hypertension 73 (2009): e35-e66.
14. Popescu SM., et al. “Hypertensive patients and their management in dentistry”. International Scholarly Research Notices (2013).
15. Waisman Gabriel. "Hipertensión arterial resistente”. Revista de la Federación Argentina de Cardiología 3 (2013): 170-173.
16. KM Habbab., et al. “Potential oral manifestations of cardiovascular drugs”. Oral Diseases8 (2010): 769-773.
17. J Guggenheimer and PA Moore. “Xerostomia: etiology, recognition and treatment”. Journal of the American Dental Association1 (2003): 61-69.
18. LM Wing., et al. “Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension”. European Journal of Clinical Pharmacology6 (1977): 463-469.
19. J Breidthardt., et al. “Long-term (5 year) experience with transdermal clonidine in the treatment of mild to moderate hypertension”. Clinical Autonomic Research6 (1993): 385-390.
20. WW Herman., et al. “New national guidelines on hypertension: a summary for dentistry”. Journal of the American Dental Association5 (2004): 576-584.
21. JS Ellis., et al. “Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study”. Journal of Periodontology1 (1999): 63-67.
22. G Kaur., et al. “Association between calcium channel blockers and gingival hyperplasia”. Journal of Clinical Periodontology7 (2010): 625-630.
23. T Tagawa., et al. “Marked gingival hyperplasia induced by nifedipine”. International Journal of Oral and Maxillofacial Surgery2 (1990): 72-73.
24. L Fattore., et al. “Gingival hyperplasia: a side effect of nifedipine and diltiazem”. Special Care in Dentistry3 (1991): 107-109.
25. RA Seymour. “Effects of medications on the periodontal tissues in health and disease”. Periodontology 20001 (2006): 120-129.
26. SG Ciancio. “Medications’ impact on oral health”. Journal of the American Dental Association 10 (2004): 1440-1480.
27. WW Herman., et al. “New national guidelines on hypertension: a summary for dentistry”. Journal of the American Dental Association5 (2004): 576-584.
28. BH Ackerman and N Kasbekar. “Disturbances of taste and smell induced by drugs”. Pharmacotherapy 3 (1997): 482-496.
29. V Musumeci., et al. “Salivary electrolytes in treated hypertensives at low or normal sodium diet”. Clinical and Experimental Hypertension2 (1993): 245-256.
30. Budenz AW. “Local anesthetics and medically complex patients”. Journal of the California Dental Association 28.8 (2000): 611-619.
31. J Little., et al. “Dental Management of the Medically Compromised Patient”. Elsevier Mosby, St Louis, Mo, USA, 8 edition (2013).
32. J Hogan and J Radhakrishnan. “The assessment and importance of hypertension in the dental setting”. Dental Clinics of North America 56 (2012): 731-745.
33. CL Hatch., et al. “Plasma catecholamine and hemodynamic responses to the placement of epinephrine-impregnated gingival retraction cord”. Oral Surgery Oral Medicine and Oral Pathology5 (1984): 540-544.

Citation

Citation: Zoilo Núñez Gil and Otto Alemán Miranda. “Risks and Complications of Dental Treatment for Cardiac Patients."Acta Scientific Dental Sciences 7.10 (2023): 73-94.

Copyright

Copyright: © 2023 Zoilo Núñez Gil and Otto Alemán Miranda. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.